DELPHARM BOUCHERVILLE CANADA INC
$60,000,000.00 CAD
- Program
- SIF Stream2- Growth
- Recipient country
- Canada
- Fiscal year
- 2024-2025
- Agreement period
- February 13, 2025 – July 1, 2051
- Reference
- ic:033-2024-2025-Q4-819706
Published purpose
This project will support the modernization of an establishment of a new manufacturing facility focused on sterile injectables in Boucherville, Quebec. The facility will primarily manufacture and produce generic sterile injectables.
In plain English AI-generated
This project supports the modernization and establishment of a new manufacturing facility for sterile injectables in Boucherville, Quebec, primarily producing generic sterile injectables.
Category: Health Primarily funds activity in Canada
Based on the published description. See how AI categorization works — the linked official record is authoritative.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.